NASDAQ
Allergy Therapeutics plc (AGYTF) has a current ratio of 0.93x as of Monday, May 25, 2026. This represents a 58.67% decrease compared to its 12-month average of 2.25x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.